<?xml version='1.0' encoding='utf-8'?>
<document id="29969356"><sentence text="Effect of citral on mouse hepatic cytochrome P450 enzymes." /><sentence text="Citral is used as a potential natural treatment for various infectious diseases" /><sentence text="" /><sentence text="To examine the effect of citral on the mRNA expression and activities of cytochrome P450 (CYP450) enzymes and establish the relationship between citral-induced liver injury and oxidative stress" /><sentence text="" /><sentence text="ICR mice were randomly divided into citral (20, 200, and 2000 mg/kglow), Tween-80, and control groups (0"><entity charOffset="73-81" id="DDI-PubMed.29969356.s6.e0" text="Tween-80" /></sentence><sentence text="9% saline), 10 mice in each group" /><sentence text=" The citral-treated groups were intragastrically administered citral for 3 d, control groups treated with 0" /><sentence text="5% Tween-80 and 0"><entity charOffset="3-11" id="DDI-PubMed.29969356.s9.e0" text="Tween-80" /></sentence><sentence text="9% saline in the same way" /><sentence text=" Liver injury and CYP450 enzymes were analyzed by analyzing the histopathological changes and the changes of related enzymes" /><sentence text="" /><sentence text="Citral treatment (2000 mg/kg) for 3 d increased serum glutamic pyruvic transaminase and glutamic oxaloacetic transaminase levels, as well as glutathione, gydroxyl radicals, malonaldehyde and total superoxide dismutase contents, but decreased the content of total antioxidant capacity"><entity charOffset="88-108" id="DDI-PubMed.29969356.s13.e0" text="glutamic oxaloacetic" /><entity charOffset="141-152" id="DDI-PubMed.29969356.s13.e1" text="glutathione" /><entity charOffset="173-186" id="DDI-PubMed.29969356.s13.e2" text="malonaldehyde" /><entity charOffset="197-207" id="DDI-PubMed.29969356.s13.e3" text="superoxide" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e0" e2="DDI-PubMed.29969356.s13.e0" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e0" e2="DDI-PubMed.29969356.s13.e1" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e0" e2="DDI-PubMed.29969356.s13.e2" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e0" e2="DDI-PubMed.29969356.s13.e3" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e1" e2="DDI-PubMed.29969356.s13.e1" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e1" e2="DDI-PubMed.29969356.s13.e2" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e1" e2="DDI-PubMed.29969356.s13.e3" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e2" e2="DDI-PubMed.29969356.s13.e2" /><pair ddi="false" e1="DDI-PubMed.29969356.s13.e2" e2="DDI-PubMed.29969356.s13.e3" /></sentence><sentence text=" In doses of 20 and 200 mg/kg groups mice, the contents of NO were decreased significantly and other changes were similar to the 2000 mg/kg group mice, but the liver damage was most severe in the 2000 mg/kg group"><entity charOffset="59-61" id="DDI-PubMed.29969356.s14.e0" text="NO" /></sentence><sentence text=" Citral induced the mRNA expression and activities of CYP450 1A2, 2D22, and 2E1 in the liver of mice at doses of 20 and 200 mg/kg" /><sentence text=" There were no changes in testing indexes in Tween-80 treated group mice"><entity charOffset="45-53" id="DDI-PubMed.29969356.s16.e0" text="Tween-80" /></sentence><sentence text=" Due to its toxic effects, the CYP induction effect of citral negatively correlated with its dose" /><sentence text=" Although the mRNA expression of CYP450 3A11 was induced by citral, its activity was not affected by low and moderate doses of citral" /><sentence text=" CYP450 3A11 activity was significantly decreased by high-dose citral" /><sentence text="" /><sentence text="Citral is hepatotoxic and induced oxidative stress in higher dose, which has a negative effect on CYP450 enzymes" /><sentence text=" These data suggest caution needs to be taken in order to avoid citral-drug interactions in human beings" /><sentence text="" /></document>